Crucial Information for Agenus Inc. Investors
Levi & Korsinsky, LLP is here to notify investors in Agenus Inc. (NASDAQ: AGEN) about an important class action securities lawsuit. If you are associated with Agenus, it is essential to understand your rights and the situation surrounding this legal action.
Understanding the Class Action Lawsuit
This lawsuit aims to recover losses for investors who believe they have been negatively impacted by recent allegations of securities fraud. The allegations cover a specific period, indicating that from early 2023 to mid-2024, there were potentially misleading claims regarding the effectiveness of Agenus's immuno-oncology products.
Details of the Alleged Fraud
The filed complaint asserts that the defendants provided false information and obscured crucial details concerning the combination therapy involving two key products, botensilimab and balstilimab. Specifically, they allegedly overstated the clinical results and commercial potential associated with these therapies.
What Should You Do Next?
If you have suffered losses in your investment with Agenus during the specified timeframe, it is imperative to act quickly. You have the opportunity to reach out to the court before the deadline. Although you can request to be appointed as lead plaintiff, it is not necessary to participate in potential recovery.
No Financial Burden to Participate
If you qualify as a class member, it is vital to know there will be no out-of-pocket expenses or fees for you. Participation in this class action does not entail any financial commitment from your end.
Why Choose Levi & Korsinsky?
With over 20 years in the field, Levi & Korsinsky has an impressive history of recovering substantial amounts for shareholders. Their dedicated team, comprising over 70 professionals, brings extensive expertise in handling complex securities litigation. They have consistently ranked among the top firms in the United States for securities litigation.
Contact Information
If you have questions or need assistance, don't hesitate to reach out. You can contact Joseph E. Levi, Esq., directly through email or telephone. Communication with Levi & Korsinsky is a critical step towards understanding your rights in this matter.
Frequently Asked Questions
What is the nature of the allegations against Agenus Inc.?
The allegations involve claims of securities fraud related to misleading communications about their immuno-oncology products' effectiveness and commercial viability.
What can affected investors do?
Affected investors should contact Levi & Korsinsky to explore their options for participating in the class action lawsuit and asserting their rights.
Is there a cost to participate in the lawsuit?
No, there are no costs for class members to participate in this lawsuit.
What is the deadline for action?
Investors have until a specified date to request to be designated as lead plaintiff or to take action regarding their rights.
How can I stay updated on this case?
Keep in touch with Levi & Korsinsky for the latest updates and information regarding the lawsuit and your rights as an investor.
